A case of ocular myasthenia gravis induced by risedronate therapy for osteoporosis in a 81 years old lady has been reported in The Journal of Postgraduate Medicine.
On Applying the Naranjo's adverse drug reactions (ADR) probability scale, a causality assessment was made which categorized this reaction as probable with a score of 7.
Source: J Postgrad Med 2007;53:274-5
http://www.jpgmonline.com/text.asp?2007/53/4/274/37525
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment